Key result
Higher lipoprotein combine index is linked to ~3.8-fold higher odds of diabetes in NSTEMI.
Why the study?
Research on non-traditional lipid indices (AIP, ACI, and LCI) has emphasized coronary disease presence or angiographic severity rather than ACS severity, and whether T2DM modifies this relationship remained unknown.
Does type 2 diabetes mellitus modify the relationship between atherogenic lipid indices (AIP, ACI, LCI) and acute coronary syndrome spectrum severity?
Cross-Sectional (n=416)
No
Does type 2 diabetes mellitus modify the relationship between atherogenic lipid indices (AIP, ACI, LCI) and acute coronary syndrome spectrum severity?
In acute coronary syndrome, atherogenic lipid indices (specifically ACI and LCI) distinguish unstable angina from myocardial infarction primarily in patients with type 2 diabetes mellitus, reflecting metabolic rather than anatomical burden.
Answers are grounded in this paper and cite their sources.
LCI may flag metabolic risk in diabetic NSTEMI; leaves open its value for ACS stratification beyond standard lipids.
Diabetic atherogenic dyslipidemia sustains residual cardiovascular burden in acute coronary syndrome (ACS) poorly reflected by LDL cholesterol. Research on non-traditional lipid indices, AIP, ACI, and LCI, has emphasized coronary disease presence or angiographic severity rather than ACS severity. Whether T2DM modifies this relationship remains unknown. This single-center study included 416 ACS patients (156 with T2DM, 260 without); lipids were sampled within 24 h of admission. AIP, ACI, and LCI were compared across UAP, NSTEMI, and STEMI by glycemic status; ROC cut-offs assessed glycemic status and coronary severity. AIP and LCI were higher in T2DM (P=0.004 and P=0.005), whereas ACI was not (P=0.091). Correlations with spectrum were weak but consistent in T2DM. ACI and LCI differed non-monotonically in the cohort and in T2DM, lowest in UAP and comparable in NSTEMI and STEMI; no index differed in non-diabetic patients. At ROC cut-offs, indices were associated with T2DM within NSTEMI (LCI OR 3.79) and STEMI, not UAP; none with vessel count. LCI was strongest and consistent. In ACS, ACI and LCI distinguish unstable angina from infarction mainly in T2DM, in a non-monotonic pattern absent in non-diabetic patients, reflecting metabolic rather than anatomical burden. T2DM modifies indices-ACS relationships, with LCI the most consistent marker. These cross-sectional findings require prospective, outcome-based validation.
No takes yet. Share an insight, caveat, or question.
Masnah (2026) conducted a cross-sectional in Acute coronary syndrome (ACS) (n=416). Atherogenic lipid indices (AIP, ACI, LCI) and type 2 diabetes mellitus (T2DM) vs. Non-diabetic ACS patients was evaluated on Association of atherogenic lipid indices (AIP, ACI, LCI) with ACS clinical spectrum (UAP, NSTEMI, STEMI) and glycemic status (OR 3.79, p=0.005).
Synapse has enriched 10 related papers. Consider them for comparative context: